Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 50 of 137 Clinical Trials

Clinical Research Trial

JCAR017-EAP-001

EXPANDED ACCESS PROTOCOL (EAP) FOR SUBJECTS RECEIVING LISOCABTAGENE MARALEUCEL THAT IS NONCONFORMING FOR COMMERCIAL RELEASE

Doctor(s) Running This Study
Mohammad H. Kazemi, MD
Clinical Research Trial

BMS CA234-0001 MalignantTumor

BMS CA234-0001 A Phase 1/1b Open-label Study of BMS-986488 as Monotherapy and Combination Therapy in Participants with Advanced Malignant Tumors

Doctor(s) Running This Study
Suresh G. Nair, MD
Clinical Research Trial

Aptis PRUJ IDE

A prospective, multi center, single Arm clinical trial of the safety and effectiveness of the Aptis Proximal Radial Ulnar Joint Prosthesis for the treatment of patients with Proximal Radioulnar joint

Doctor(s) Running This Study
Paul A. Sibley, DO
Clinical Research Trial

WF2304-A172401 Multi-Site Cancer

Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-GY026 Gynecological Cancer

A PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN ALONE OR COMBINED WITH EITHER TRASTUZUMAB AND HYALURONIDASE-OYSK (HERCEPTIN HYLECTA) OR PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF (PHESGO) IN HER2 POSITIVE, STAGE I-IV ENDOMETRIAL SEROUS CARCINOMA

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-GY026 Gynecological Cancer

A PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN ALONE OR COMBINED WITH EITHER TRASTUZUMAB AND HYALURONIDASE-OYSK (HERCEPTIN HYLECTA) OR PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF (PHESGO) IN HER2 POSITIVE, STAGE I-IV ENDOMETRIAL SEROUS CARCINOMA

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

S1802 Prostate Cancer

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer).

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

S1802 Prostate Cancer

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer).

Doctor(s) Running This Study
Maged F. Khalil, MD